Maybe we were over optimistic or we misinterpreted the recent upbeat comments of the directors -hard for them to find balance in expressing the progress in an upbeat way but not too upbeat neither too flat nor too subdued etc.
Maybe too early to expect bigger sales at a quarter we know is lower in Europe and many institutions in the US have been waiting for FDA approval, so personally I am neither concerned nor disappointed I more or less expected it but --- ---BUT I will expect to see some marked difference in the next quarter now that FDA approval is not an impediment anymore and the winter will bring all backpackers back home to start their testing, Lol!
If next quarter all still sitting there within the ''same ol' same ol' '' pattern then I will know it will take ...another ...five years...
(that's the usual term of ...''forget it'', isn't???...)
CST Price at posting:
0.0¢ Sentiment: None Disclosure: Held
